118 related articles for article (PubMed ID: 37548547)
1. Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastases.
Morshed RA; Cummins DD; Nguyen MP; Saggi S; Vasudevan HN; Braunstein SE; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Daras M; Hervey-Jumper SL; Aghi MK
J Neurosurg; 2024 Feb; 140(2):328-337. PubMed ID: 37548547
[TBL] [Abstract][Full Text] [Related]
2. Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.
Morshed RA; Saggi S; Cummins DD; Molinaro AM; Young JS; Viner JA; Villanueva-Meyer JE; Goldschmidt E; Boreta L; Braunstein SE; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Aghi MK; Daras M
J Neurosurg; 2023 Aug; 139(2):402-413. PubMed ID: 36640095
[TBL] [Abstract][Full Text] [Related]
3. Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver Reliability.
Turner BE; Prabhu RS; Burri SH; Brown PD; Pollom EL; Milano MT; Weiss SE; Iv M; Fischbein N; Soliman H; Lo SS; Chao ST; Cox BW; Murphy JD; Li G; Gephart MH; Nagpal S; Atalar B; Azoulay M; Thomas R; Tillman G; Durkee BY; Shah JL; Soltys SG
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):579-586. PubMed ID: 31605786
[TBL] [Abstract][Full Text] [Related]
4. Association of CDKN2A alterations with increased postoperative seizure risk after resection of brain metastases.
Cummins DD; Garcia JH; Nguyen MP; Saggi S; Chung JE; Goldschmidt E; Berger MS; Theodosopoulos PV; Chang EF; Daras M; Hervey-Jumper SL; Aghi MK; Morshed RA
Neurosurg Focus; 2023 Aug; 55(2):E14. PubMed ID: 37527678
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.
Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Patel KR; Curran WJ; Breen WG; Brown PD; Jethwa KR; Grills IS; Arden JD; Foster LM; Manning MA; Stern JD; Soltys SG; Burri SH
Neuro Oncol; 2019 Aug; 21(8):1049-1059. PubMed ID: 30828727
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.
Morshed RA; Nguyen MP; Cummins DD; Saggi S; Young JS; Haddad AF; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Daras M; Aghi MK
Neurooncol Adv; 2023; 5(1):vdad007. PubMed ID: 36915611
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of Over 500 Cavities.
Shi S; Sandhu N; Jin MC; Wang E; Jaoude JA; Schofield K; Zhang C; Liu E; Gibbs IC; Hancock SL; Chang SD; Li G; Hayden-Gephart M; Adler JR; Soltys SG; Pollom EL
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):764-771. PubMed ID: 31785338
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis.
Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Buchwald ZS; Curran WJ; Patel KR; Breen WG; Brown PD; Jethwa KR; Grills IS; Arden JD; Foster LM; Manning MA; Vaslow ZK; Burri SH; Soltys SG
Adv Radiat Oncol; 2021; 6(2):100644. PubMed ID: 33732962
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
11. Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery.
Teyateeti A; Brown PD; Mahajan A; Laack NN; Pollock BE
Neurooncol Adv; 2021; 3(1):vdab036. PubMed ID: 33860228
[TBL] [Abstract][Full Text] [Related]
12. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
13. Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.
Cheok SK; Yu C; Feng JJ; Briggs RG; Chow F; Hwang L; Ye JC; Attenello FJ; Tran D; Chang E; Zada G
Neurosurg Focus; 2023 Aug; 55(2):E9. PubMed ID: 37527673
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations associated with rapid progression of brain metastases.
Uggerly ASV; Cummins DD; Nguyen MP; Saggi S; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Daras M; Aghi MK; Morshed RA
Neurosurg Focus; 2023 Aug; 55(2):E15. PubMed ID: 37527682
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases.
Eitz KA; Lo SS; Soliman H; Sahgal A; Theriault A; Pinkham MB; Foote MC; Song AJ; Shi W; Redmond KJ; Gui C; Kumar AMS; Machtay M; Meyer B; Combs SE
JAMA Oncol; 2020 Dec; 6(12):1901-1909. PubMed ID: 33057566
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.
Huang AJ; Huang KE; Page BR; Ayala-Peacock DN; Lucas JT; Lesser GJ; Laxton AW; Tatter SB; Chan MD
J Neurooncol; 2014 Oct; 120(1):163-9. PubMed ID: 25048529
[TBL] [Abstract][Full Text] [Related]
17. Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases.
Jagannathan J; Yen CP; Ray DK; Schlesinger D; Oskouian RJ; Pouratian N; Shaffrey ME; Larner J; Sheehan JP
J Neurosurg; 2009 Sep; 111(3):431-8. PubMed ID: 19361267
[TBL] [Abstract][Full Text] [Related]
18. Salvage Surgery for Local Control of Brain Metastases After Previous Stereotactic Radiosurgery: A Single-Center Series.
Cummins DD; Morshed RA; Chavez MM; Avalos LN; Sudhakar V; Chung JE; Gallagher A; Saggi S; Daras M; Braunstein S; Theodosopoulos PV; McDermott MW; Aghi MK
World Neurosurg; 2022 Feb; 158():e323-e333. PubMed ID: 34740830
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu HG; Curran WJ; Crocker IR; Patel KR
Neurosurgery; 2019 Nov; 85(5):632-641. PubMed ID: 30335175
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD; Coxon AT; Huang J; Abraham CD; Dowling JL; Leuthardt EC; Dunn GP; Kim AH; Dacey RG; Zipfel GJ; Evans J; Filiput EA; Chicoine MR
Neurosurg Focus; 2022 Nov; 53(5):E8. PubMed ID: 36321291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
